Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baidu
BIDU
|
+$462M |
| 2 |
AGN
Allergan plc
AGN
|
+$390M |
| 3 |
AT&T
T
|
+$371M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$353M |
| 5 |
NextEra Energy
NEE
|
+$326M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.97B |
| 2 |
Meta Platforms (Facebook)
META
|
+$435M |
| 3 |
Pfizer
PFE
|
+$377M |
| 4 |
GE Aerospace
GE
|
+$354M |
| 5 |
Starbucks
SBUX
|
+$323M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.43% |
| 2 | Technology | 12.71% |
| 3 | Consumer Staples | 9.79% |
| 4 | Financials | 8.2% |
| 5 | Utilities | 8.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HMLP
1351
DELISTED
HOEGH LNG PARTNERS LP
HMLP
| $7.29M | 0.01% |
994,169
+106,070
| +12% | +$1.31M |
|
1352
Clarus
CLAR
$129M
| $7.28M | 0.01% |
746,344
-65,188
| -8% | -$786K |
|
1353
InterContinental Hotels
IHG
$23.9B
| $7.28M | 0.01% |
172,757
+31,393
| +22% | +$1.76M |
|
|
LGF.B
1354
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $7.27M | 0.01% |
1,303,334
+225,841
| +21% | +$1.89M |
|
|
SOGO
1355
DELISTED
Sogou Inc. American Depositary Shares, each representing one Class A Ordinary Share
SOGO
| $7.27M | 0.01% |
2,164,410
+101,394
| +5% | +$431K |
|
1356
Columbus McKinnon
CMCO
$620M
| $7.23M | 0.01% |
289,100
+23,100
| +9% | +$768K |
|
1357
Sierra Bancorp
BSRR
$528M
| $7.2M | 0.01% |
409,631
-11,200
| -3% | -$272K |
|
|
ESSA
1358
DELISTED
ESSA Bancorp
ESSA
| $7.2M | 0.01% |
527,328
-15,833
| -3% | -$254K |
|
|
AVDL
1359
DELISTED
Avadel Pharmaceuticals
AVDL
| $7.19M | 0.01% |
905,806
+51,800
| +6% | +$398K |
|
1360
H.B. Fuller
FUL
$3.2B
| $7.18M | 0.01% |
257,100
+131,000
| +104% | +$5.5M |
|
1361
Conduent
CNDT
$267M
| $7.18M | 0.01% |
2,929,200
-897,431
| -23% | -$3.56M |
|
|
ZEPP
1362
Zepp Health
ZEPP
$67M
| $7.17M | 0.01% |
136,711
-32,333
| -19% | -$1.75M |
|
1363
UFP Industries
UFPI
$5.24B
| $7.16M | 0.01% |
192,509
+1,000
| +0.5% | +$45.9K |
|
|
HMTV
1364
DELISTED
Hemisphere Media Group, Inc.
HMTV
| $7.14M | 0.01% |
836,000
+40,000
| +5% | +$496K |
|
|
WMC
1365
DELISTED
Western Asset Mortgage Capital Corporation
WMC
| $7.11M | 0.01% |
310,576
+6,061
| +2% | +$551K |
|
1366
Blue Bird Corp
BLBD
$2.43B
| $7.11M | 0.01% |
650,418
-73,586
| -10% | -$1.34M |
|
1367
Silicon Motion
SIMO
$8.36B
| $7.1M | 0.01% |
+193,779
| New | +$8.37M |
|
1368
Ametek
AME
$58.4B
| $7.08M | 0.01% |
98,251
-112,399
| -53% | -$10.1M |
|
1369
Clearfield
CLFD
$459M
| $7.07M | 0.01% |
596,673
+5,074
| +0.9% | +$60.9K |
|
|
AE
1370
DELISTED
Adams Resources & Energy Inc
AE
| $7.07M | 0.01% |
300,776
-17,824
| -6% | -$557K |
|
1371
PNC Financial Services
PNC
$102B
| $7.04M | 0.01% |
+73,499
| New | +$9.87M |
|
1372
First Financial Corp
THFF
$979M
| $7.02M | 0.01% |
208,059
+12,782
| +7% | +$515K |
|
|
ARA
1373
DELISTED
American Renal Associates Holdings, Inc
ARA
| $7M | 0.01% |
1,059,275
+22,575
| +2% | +$197K |
|
|
RVNC
1374
DELISTED
Revance Therapeutics, Inc.
RVNC
| $7M | 0.01% |
472,700
-204,773
| -30% | -$4.24M |
|
1375
Eagle Materials
EXP
$6.7B
| $6.96M | 0.01% |
119,200
-132,100
| -53% | -$10.5M |
|
Similar funds
Renaissance Technologies's Q1 2020 Portfolio in Review
As of Q1 2020, Renaissance Technologies held 4,047 positions worth $103B, down 21% from $130B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Renaissance Technologies's Q1 2020 filing shows 573 new, 1,474 increased, 1,328 reduced and 645 closed positions. Its largest new stake was AT&T: 13,563,699 shares worth $299M. The largest sale was Tesla, an estimated $1.97B.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 21% a quarter earlier, followed by Technology and Consumer Staples.
- Renaissance Technologies's largest Q1 2020 buy was AT&T: 13,563,699 shares worth $299M.
- Renaissance Technologies added most to Baidu in Q1 2020, an estimated $462M increase.
- Renaissance Technologies's biggest Q1 2020 reduction was Tesla, cutting an estimated $1.97B.
- Renaissance Technologies fully exited Phillips 66 in Q1 2020, selling an estimated $214M.
- Renaissance Technologies's ten largest holdings make up 15% of its $103B portfolio in Q1 2020.
- Renaissance Technologies opened 573 new positions and closed 645 in Q1 2020.
- Renaissance Technologies's portfolio value fell 21% quarter-over-quarter to $103B.
Based on Renaissance Technologies's 13F filing for Q1 2020, filed 14 May 2020.